Related Experiment Video
Updated: Jul 20, 2026

Fingerprinting Cardiolipin in Leukocytes by Mass Spectrometry for a Rapid Diagnosis of Barth Syndrome
Published on: March 23, 2022
Barth syndrome, a human disorder of cardiolipin metabolism
1Department of Anesthesiology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA. michael.schlame@med.nyu.edu
Insights
Barth syndrome, a genetic disorder, stems from tafazzin gene mutations, impacting cardiolipin in mitochondria. This leads to heart failure, myopathy, and growth issues, highlighting tafazzin's role in mitochondrial function.
Area of Science:
- Biochemistry
- Genetics
- Cell Biology
Background:
- Barth syndrome is an X-linked recessive disorder caused by mutations in the tafazzin gene.
- It is characterized by reduced cardiolipin levels and altered cardiolipin composition in mitochondria.
- Clinical manifestations include heart failure, myopathy, neutropenia, and growth retardation.
Purpose of the Study:
- To provide an overview of the molecular basis of Barth syndrome.
- To elucidate the role of the tafazzin gene and its protein product in cardiolipin metabolism.
- To understand how tafazzin dysfunction impacts mitochondrial structure and function.
Main Methods:
- Review of existing literature on Barth syndrome, tafazzin, and cardiolipin metabolism.
- Analysis of the biochemical function of tafazzin as a phospholipid acyltransferase.
- Examination of the consequences of tafazzin inhibition on cardiolipin remodeling and mitochondrial integrity.
Main Results:
- Tafazzin is identified as a key enzyme in the acyl-specific remodeling of cardiolipin.
- This remodeling process is crucial for maintaining structural uniformity and molecular symmetry of cardiolipin species.
- Inhibition of tafazzin leads to impaired cardiolipin remodeling, affecting mitochondrial architecture and function.
Conclusions:
- Tafazzin plays a critical role in maintaining mitochondrial health through cardiolipin remodeling.
- Dysfunctional tafazzin disrupts cardiolipin homeostasis, leading to the pathologies observed in Barth syndrome.
- Understanding this molecular pathway offers insights into potential therapeutic strategies for Barth syndrome.
Abstract:
Barth syndrome is an X-linked recessive disease caused by mutations in the tafazzin gene. Patients have reduced concentration and altered composition of cardiolipin, the specific mitochondrial phospholipid, and they have variable clinical findings, often including heart failure, myopathy, neutropenia, and growth retardation. This article provides an overview of the molecular basis of Barth syndrome. It is argued that tafazzin, a phospholipid acyltransferase, is involved in acyl-specific remodeling of cardiolipin, which promotes structural uniformity and molecular symmetry among the cardiolipin molecular species. Inhibition of this pathway leads to changes in mitochondrial architecture and function.
Related Concept Videos
Inborn Errors of Metabolism
Overview of Lipid Metabolism
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Protein Import into the Peroxisomes
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...
Lipid Catabolism
Barrett Esophagus-I: Introduction
This constant acid exposure transforms the esophagus's pink mucosal lining (stratified squamous epithelium) into a type of lining more similar...
Cardiomyopathy III: Hypertrophic Cardiomyopathy

